Information  X 
Enter a valid email address

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

By BFN News | 10:10 AM | Friday 09 November, 2018


Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1950p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t